Pharma companies need to begin now to strategically plan for 2028–2029 implementation of PBM reforms.

In part two of this series, we dive into the voluntary Generous CMMI demo and what it means for manufacturers.

National Pharmaceutical Counsel sponsored Spotlight Education Panel Discussion on Oct 2, 2024 with Sarah Edmond, President and CEO.

Reflect on the biopharmaceutical industry's role in solving global health challenges and how to address misunderstandings about brining medicines to market.